Related Experiment Video
Updated: Jun 22, 2026

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Noninvasive detection of early pulmonary vascular dysfunction in scleroderma
F Reichenberger1, R Voswinckel, R Schulz
1University Giessen Lung Centre, University Hospital Giessen, Germany. frank.reichenberger@innere.med.uni-giessen.de
Respiratory Medicine
|June 6, 2009
Summary
Early screening for pulmonary vascular dysfunction in scleroderma patients is possible. Echocardiography during exercise and hypoxia can identify a hypertensive pulmonary vascular response, a precursor to pulmonary arterial hypertension.
Area of Science:
- Cardiology
- Rheumatology
- Pulmonology
Background:
- Pulmonary arterial hypertension (PAH) is a severe complication in patients with scleroderma.
- Early diagnosis of PAH in scleroderma is crucial for timely intervention and improved outcomes.
Purpose of the Study:
- To investigate the utility of non-invasive assessment of pulmonary circulation during exercise and hypoxia for screening pulmonary vascular dysfunction in scleroderma.
- To identify early signs of hypertensive pulmonary vascular response in scleroderma patients.
Main Methods:
- 33 scleroderma patients with normal resting pulmonary artery pressure underwent echocardiography during physical exercise and hypoxia.
- A hypertensive pulmonary vascular reaction was diagnosed based on elevated systolic pulmonary artery pressure (sPAP) during exercise or hypoxia.
Main Results:
- Sixteen patients (48%) exhibited a hypertensive pulmonary vascular response, with significantly higher sPAP during exercise and hypoxia compared to controls.
- The sPAP/VO2 max ratio was significantly higher in patients with a hypertensive response (0.76 vs. 0.49, p<0.0001).
- Over a 3-year follow-up, one patient with a hypertensive response developed manifest pulmonary arterial hypertension.
Conclusions:
- Non-invasive assessment of pulmonary circulation using echocardiography during exercise and/or hypoxia is effective for screening pulmonary vascular dysfunction in scleroderma.
- This method can identify patients at risk for developing pulmonary arterial hypertension.
- Early detection of hypertensive pulmonary vascular response may allow for earlier management strategies in scleroderma.

